Esterline, Janus Capital, and Other Stocks Insiders Are Buying
Below are some stocks that have seen insider buying recently.
Insiders may sell shares for any number of reasons, but there is really only one reason insiders buy shares of a company: They believe the stock price will move higher and they want to profit from it. Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company to snap up shares. Below are some stocks that have seen insider buying recently.
AGCO (NYSE:AGCO): One director purchased more than 330,000 shares of this agricultural equipment maker in September worth almost $11 million. AGCO recently has been expanding into France, and it has a market capitalization of about $4.6 billion. Its return on equity is about 22% and its price-to-earnings (P/E) ratio is less than the industry average. Shares jumped more than 12% in the past month, but the stock
Esterline Technologies (NYSE:ESL): The general counsel and three directors purchased 6,500 shares worth more than $370,000 of this aerospace and defense company last week. The company issued rosy guidance at the end of August. Its market cap is near $1.7 billion and it has a long-term EPS growth forecast of more than 16%. But the P/E ratio is higher than the industry average. The share price has fallen more than 21% over the past six months. In that time, the stock has underperformed Eaton (NYSE:ETN) and Honeywell International (NYSE:HON).
Janus Capital Group (NYSE:JNS): Beneficial owner Dai-ichi Life Insurance purchased more than four million shares of this asset management company this past week worth more than $39.3 million. Dai-ichi's stake has risen to about 14%, or more than 12.5 million shares. Janus Capital's market cap is about $1.7 billion and its dividend yield is about 2.5%. The 15.8 P/E ratio is in line with the industry average. Shares are trading near the 52-week high after rising more than 42% since the beginning of the year, easily outperforming the S&P 500.
Opko Health (NYSE:OPK): The chairman continues to periodically buy batches of shares, as he has done since last November. He has bought more than 220,000 shares in the past week worth more than $920,000. This Miami-based health care company has a market cap of near $1.2 billion. Short interest is a hefty 22% of the float. Shares have fallen more than 6% in the past month and are now down more than 14% year to date. Over the past six months, the stock has underperformed competitors such as Allergan (NYSE:AGN).
Republic Services (NYSE:RSG): Last week, beneficial owner Cascade Investment bought more than $1.6 million shares, worth more than $47.6 million, in this Phoenix, Arizona -based waste disposal company. Its market cap is about $10 billion. Analysts expect Republic Services to report declining earnings and revenue in the current quarter. The long-term EPS growth forecast is only 6.6%. The stock has pulled back more than 3% in the past two weeks. It has narrowly underperformed competitor Waste Management (NYSE:WM) over the past six months.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.